Januvia and Hepatic function abnormal - a phase IV clinical study of FDA data
Summary:
Hepatic function abnormal is reported as a side effect among people who take Januvia (sitagliptin phosphate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amaryl, and have High blood pressure.
The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Januvia. It is created by eHealthMe based on reports of 71,642 people who have side effects when taking Januvia from the FDA, and is updated regularly.
What is Januvia?
Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.
What is Hepatic function abnormal?
Hepatic function abnormal is found to be associated with 1,434 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
71,642 people reported to have side effects when taking Januvia.
Among them, 269 people (0.38%) have Hepatic function abnormal.
Among these 269 people:
How long have people been on Januvia when they have Hepatic function abnormal? *
What is the gender of people who have Hepatic function abnormal when taking Januvia? *
What is the age of people who have Hepatic function abnormal when taking Januvia? *
What are other drugs people take besides Januvia? *
What are other side effects people have besides Hepatic function abnormal? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Januvia and have Hepatic function abnormal?
- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Januvia:
- Januvia (72,818 reports)
Hepatic function abnormal treatments and more:
- Hepatic function abnormal (47,051 reports)
How severe was Hepatic function abnormal and when was it recovered:
Expand to all the drugs that have ingredients of sitagliptin phosphate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Januvia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hepatic function abnormal:
- Hepatic function abnormal (1,434 drugs)
Browse all the conditions that are associated with Hepatic function abnormal:
- Hepatic function abnormal (2,021 conditions)
Related publications that referenced our studies
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on sitagliptin phosphate (the active ingredients of Januvia) and Januvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Amitiza and Dicyclomine Hydrochloride - 2 seconds ago
- Could Mekinist cause C-Reactive Protein Increased? - 3 seconds ago
- Could Demadex cause Insomnia? - 8 seconds ago
- Drug interactions of Hydromorphone Hydrochloride and Melatonin - 13 seconds ago
- Could Verapamil Hcl cause Cardiogenic Shock? - 20 seconds ago
- Could Tacrolimus cause Acute Hepatic Failure? - 26 seconds ago
- Could Metformin cause Hair Color Changes? - 38 seconds ago
- Could Ipratropium Bromide cause Tumor? - 44 seconds ago
- Could Nifedipine cause Jaundice Neonatal? - 49 seconds ago
- Doxazosin Mesylate vs. Ibu, side effect and effectiveness comparison - 58 seconds ago